Award
National Cancer Institute 5R37CA283552-03
Targeting DHX9 to trigger viral mimicry and immunotherapy responsiveness in Small Cell Lung Cancer (SCLC)
Recipient
RESEARCH INST OF FOX CHASE CAN CTR
Award Amount
$649,679.00
Ceiling
$649,679.00
Awarded
July 15, 2026
Identifier
5R37CA283552-03
Research project awarded to study DHX9's role in Small Cell Lung Cancer to improve immunotherapy outcomes.
Description
This project involves studying the role of DHX9 in tumor immunity and genomic stability, with a focus on Small Cell Lung Cancer. It includes the development of a small molecule inhibitor and aims to enhance immunotherapy responses.